EP2190819 - QUATERNARY OPIOID CARBOXAMIDES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 31.03.2017 Database last updated on 31.08.2024 | Most recent event Tooltip | 17.08.2018 | Lapse of the patent in a contracting state New state(s): BG | published on 19.09.2018 [2018/38] | Applicant(s) | For all designated states RENSSELAER POLYTECHNIC INSTITUTE J Bldg. 110 8th Street Troy, NY 12180 / US | [2010/22] | Inventor(s) | 01 /
WENTLAND, Mark, P. 4675 Telescope Avenue Carlsbad, CA 92008 / US | [2016/20] |
Former [2010/22] | 01 /
WENTLAND, Mark, P. 9 Dennin Drive Menands, New York 12204 / US | Representative(s) | Graf von Stosch, Andreas, et al Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstraße 22 80538 München / DE | [2016/21] |
Former [2010/22] | Graf von Stosch, Andreas, et al Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München / DE | Application number, filing date | 08797495.2 | 08.08.2008 | [2010/22] | WO2008US72632 | Priority number, date | US20070954960P | 09.08.2007 Original published format: US 954960 P | [2010/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009023567 | Date: | 19.02.2009 | Language: | EN | [2009/08] | Type: | A1 Application with search report | No.: | EP2190819 | Date: | 02.06.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.02.2009 takes the place of the publication of the European patent application. | [2010/22] | Type: | B1 Patent specification | No.: | EP2190819 | Date: | 25.05.2016 | Language: | EN | [2016/21] | Search report(s) | International search report - published on: | EP | 19.02.2009 | Classification | IPC: | C07D221/26, C07D221/28, C07D489/00, A61K31/485 | [2010/22] | CPC: |
A61K31/485 (EP,NO,US);
C07D221/28 (NO);
A61P1/00 (EP);
A61P1/08 (EP);
A61P1/10 (EP);
A61P11/14 (EP);
A61P17/04 (EP);
A61P25/04 (EP);
A61P25/20 (EP);
A61P43/00 (EP);
A61P7/10 (EP);
C07D215/20 (EP,US);
C07D401/12 (EP,US);
C07D405/06 (EP,US);
C07D405/12 (EP,US);
C07D471/04 (EP,US);
C07D487/08 (EP,US);
C07D489/08 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2016/21] |
Former [2010/22] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | 02.03.2010 | BA | 02.03.2010 | MK | 02.03.2010 | RS | 02.03.2010 | Title | German: | QUATERNÄRE OPIATCARBOXAIMDE | [2010/22] | English: | QUATERNARY OPIOID CARBOXAMIDES | [2010/22] | French: | CARBOXAMIDES OPIOÏDES QUATERNAIRES | [2010/22] | Entry into regional phase | 02.03.2010 | National basic fee paid | 02.03.2010 | Designation fee(s) paid | 02.03.2010 | Examination fee paid | Examination procedure | 02.03.2010 | Amendment by applicant (claims and/or description) | 02.03.2010 | Examination requested [2010/22] | 24.09.2010 | Despatch of a communication from the examining division (Time limit: M06) | 21.03.2011 | Reply to a communication from the examining division | 25.04.2012 | Despatch of a communication from the examining division (Time limit: M04) | 07.05.2012 | Despatch of a communication from the examining division (Time limit: M04) | 17.09.2012 | Reply to a communication from the examining division | 14.04.2014 | Despatch of a communication from the examining division (Time limit: M06) | 23.10.2014 | Reply to a communication from the examining division | 09.11.2015 | Cancellation of oral proceeding that was planned for 24.11.2015 | 24.11.2015 | Date of oral proceedings (cancelled) | 07.01.2016 | Communication of intention to grant the patent | 13.04.2016 | Fee for grant paid | 13.04.2016 | Fee for publishing/printing paid | 13.04.2016 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.09.2010 | Opposition(s) | 28.02.2017 | No opposition filed within time limit [2017/18] | Fees paid | Renewal fee | 31.08.2010 | Renewal fee patent year 03 | 11.08.2011 | Renewal fee patent year 04 | 10.08.2012 | Renewal fee patent year 05 | 19.08.2013 | Renewal fee patent year 06 | 13.08.2014 | Renewal fee patent year 07 | 10.08.2015 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 08.08.2008 | AT | 25.05.2016 | BG | 25.05.2016 | CY | 25.05.2016 | CZ | 25.05.2016 | DK | 25.05.2016 | EE | 25.05.2016 | FI | 25.05.2016 | HR | 25.05.2016 | IS | 25.05.2016 | LT | 25.05.2016 | LV | 25.05.2016 | MC | 25.05.2016 | PL | 25.05.2016 | RO | 25.05.2016 | SE | 25.05.2016 | SI | 25.05.2016 | SK | 25.05.2016 | TR | 25.05.2016 | LU | 08.08.2016 | NO | 25.08.2016 | GR | 26.08.2016 | MT | 31.08.2016 | PT | 26.09.2016 | [2018/38] |
Former [2018/33] | HU | 08.08.2008 | |
AT | 25.05.2016 | ||
CY | 25.05.2016 | ||
CZ | 25.05.2016 | ||
DK | 25.05.2016 | ||
EE | 25.05.2016 | ||
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
IS | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
MC | 25.05.2016 | ||
PL | 25.05.2016 | ||
RO | 25.05.2016 | ||
SE | 25.05.2016 | ||
SI | 25.05.2016 | ||
SK | 25.05.2016 | ||
TR | 25.05.2016 | ||
LU | 08.08.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
MT | 31.08.2016 | ||
PT | 26.09.2016 | ||
Former [2018/29] | HU | 08.08.2008 | |
AT | 25.05.2016 | ||
CY | 25.05.2016 | ||
CZ | 25.05.2016 | ||
DK | 25.05.2016 | ||
EE | 25.05.2016 | ||
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
MC | 25.05.2016 | ||
PL | 25.05.2016 | ||
RO | 25.05.2016 | ||
SE | 25.05.2016 | ||
SI | 25.05.2016 | ||
SK | 25.05.2016 | ||
TR | 25.05.2016 | ||
LU | 08.08.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2018/28] | HU | 08.08.2008 | |
AT | 25.05.2016 | ||
CY | 25.05.2016 | ||
CZ | 25.05.2016 | ||
DK | 25.05.2016 | ||
EE | 25.05.2016 | ||
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
MC | 25.05.2016 | ||
PL | 25.05.2016 | ||
RO | 25.05.2016 | ||
SE | 25.05.2016 | ||
SI | 25.05.2016 | ||
SK | 25.05.2016 | ||
LU | 08.08.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2017/37] | AT | 25.05.2016 | |
CZ | 25.05.2016 | ||
DK | 25.05.2016 | ||
EE | 25.05.2016 | ||
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
MC | 25.05.2016 | ||
PL | 25.05.2016 | ||
RO | 25.05.2016 | ||
SE | 25.05.2016 | ||
SI | 25.05.2016 | ||
SK | 25.05.2016 | ||
LU | 08.08.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2017/23] | AT | 25.05.2016 | |
CZ | 25.05.2016 | ||
DK | 25.05.2016 | ||
EE | 25.05.2016 | ||
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
MC | 25.05.2016 | ||
PL | 25.05.2016 | ||
RO | 25.05.2016 | ||
SE | 25.05.2016 | ||
SI | 25.05.2016 | ||
SK | 25.05.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2017/17] | AT | 25.05.2016 | |
CZ | 25.05.2016 | ||
DK | 25.05.2016 | ||
EE | 25.05.2016 | ||
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
MC | 25.05.2016 | ||
PL | 25.05.2016 | ||
RO | 25.05.2016 | ||
SE | 25.05.2016 | ||
SK | 25.05.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2017/11] | AT | 25.05.2016 | |
CZ | 25.05.2016 | ||
DK | 25.05.2016 | ||
EE | 25.05.2016 | ||
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
PL | 25.05.2016 | ||
RO | 25.05.2016 | ||
SE | 25.05.2016 | ||
SK | 25.05.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2017/10] | CZ | 25.05.2016 | |
DK | 25.05.2016 | ||
EE | 25.05.2016 | ||
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
PL | 25.05.2016 | ||
RO | 25.05.2016 | ||
SE | 25.05.2016 | ||
SK | 25.05.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2017/09] | CZ | 25.05.2016 | |
DK | 25.05.2016 | ||
EE | 25.05.2016 | ||
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
RO | 25.05.2016 | ||
SE | 25.05.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2017/07] | DK | 25.05.2016 | |
FI | 25.05.2016 | ||
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
SE | 25.05.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2016/52] | FI | 25.05.2016 | |
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
SE | 25.05.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2016/51] | FI | 25.05.2016 | |
HR | 25.05.2016 | ||
LT | 25.05.2016 | ||
LV | 25.05.2016 | ||
NO | 25.08.2016 | ||
GR | 26.08.2016 | ||
PT | 26.09.2016 | ||
Former [2016/49] | FI | 25.05.2016 | |
LT | 25.05.2016 | ||
NO | 25.08.2016 | ||
Former [2016/46] | LT | 25.05.2016 | |
NO | 25.08.2016 | Cited in | International search | [X]GB874217 (ALBERT BOEHRINGER, et al) [X] 1 * pages 2-3; examples 1-11 *; | [X]DE2254298 (BOEHRINGER SOHN INGELHEIM) [X] 1 * page 51; compound IX *; | [A]US4032529 (WENTLAND MARK P, et al) [A] 2-28 * column 24; claim 1 *; | [XD]US4176186 (GOLDBERG LEON I [US], et al) [XD] 1 * columns 3-7; examples 1-12 *; | [X]WO9725331 (SMITHKLINE BEECHAM SPA [IT], et al) [X] 2-28 * page 10, line 9 * * page 42; claim 1 *; | [X]ES2121553 (UNIV SANTIAGO COMPOSTELA [ES]) [X] 1 * page 4; compounds 13-16 *; | [A]WO0236573 (RENSSELAER POLYTECH INST [US], et al) [A] 2-28 * page 35; claim 1 *; | [X]US2005176645 (MICKLE TRAVIS [US], et al) [X] 1 * figure 1 *; | [A]WO2007022535 (PHARMACOFORE INC [US], et al) [A] 2-28 * pages 75-77; claims 9-12; compounds IV-VII *; | [A] - WENTLAND M P ET AL, "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocine", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, (20050516), vol. 15, no. 10, ISSN 0960-894X, pages 2547 - 2551, XP004877722 [A] 2-28 * page 2547; figure 1 * DOI: http://dx.doi.org/10.1016/j.bmcl.2005.03.056 | Examination | US6784187 | by applicant | - RUSSELL ET AL., EUR./.PHARM., (1982), vol. 78, pages 255 - 61 |